Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viiv Healthcare CofiledCriticalViiv Healthcare Co
Publication of AR122350A1publicationCriticalpatent/AR122350A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere al tratamiento contra el Virus de Inmunodeficiencia Humana (HIV). En particular, la invención se refiere a una composición farmacéutica que comprende cabotegravir o una sal apta para uso farmacéutico del mismo, polietilenglicol y poloxámero que es útil para el tratamiento de larga duración contra el HIV.The present invention refers to the treatment against the Human Immunodeficiency Virus (HIV). In particular, the invention relates to a pharmaceutical composition comprising cabotegravir or a pharmaceutically acceptable salt thereof, polyethylene glycol and poloxamer which is useful for long-term treatment against HIV.
Compounds derived from polycyclic carbamoylpyridone; pharmaceutical composition comprising them; and its use for the treatment of a hiv infection in a human who has or is at risk of having the infection.